Delcath's cancer system faces FDA setback, shares tank - Reuters
Delcath's cancer system faces FDA setback, shares tankReuters(Reuters) - Delcath Systems Inc said US health regulators refused to accept the marketing application for its cancer drug delivery system, sending its shares down 36 percent in early trade. The company expects to submit a formal meeting request this ...and more��
Blog Content
Post a Comment